Machine learning and explainable artificial intelligence to predict pathologic stage in men with localized prostate cancer

Documenti analoghi

• Impact of PSA nadir, PSA response and time to PSA nadir on overall survival in real‐world setting of metastatic hormone‐sensitive prostate cancer patients
  di: Mike Wenzel, et al.
  Pubblicazione: (2024)
• Survival of patients with lymph node versus bone versus visceral metastases according to CHAARTED/LATITUDE criteria in the era of intensified combination therapies for metastatic hormone‐sensitive prostate cancer
  di: Mike Wenzel, et al.
  Pubblicazione: (2024)
• Lower urinary tract symptoms in elderly men: Considerations for prostate cancer testing
  di: Stephen Schmit, et al.
  Pubblicazione: (2024)
• Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome
  di: Eli Marie Grindedal, et al.
  Pubblicazione: (2024)
• Impact of Pelvic Lymph Node Dissection on Early Oncological Outcomes in Intermediate‐Risk Prostate Cancer Patients With Node‐Negative PSMA PET
  di: Baris Esen, et al.
  Pubblicazione: (2025)